[lcus_masonry_article] Case Study: A Biotech Evaluates the Alzheimer’s Cure Discovery for a Multi-Mechanism Program A biotech focused on neurodegenerative disease wanted to expand beyond amyloid-only approaches. They were interested in a research package that targeted Alzheimer’s through multiple mechanisms—amyloid, tau, neuroinflammation, neuronal regeneration—with a consistent methodology and documentation suitable for partnership and regulatory planning. They […]
content by LCUS
Product Insight – Four Mechanisms One Goal, Evaluating Multi-Mechanism Alzheimer’s Research
[lcus_masonry_article] Product Insight: Four Mechanisms, One Goal—Evaluating Multi-Mechanism Alzheimer’s Research Alzheimer’s research has long emphasized amyloid and tau. A cure will likely require addressing multiple mechanisms in concert. The Alzheimer’s Cure Discovery product targets four: amyloid plaque reduction, tau protein regulation, neuroinflammation reduction, and neuronal regeneration. The product insight is how to evaluate it: you […]